United States· US:0003-1614_275a2584-65d6-40f8-8aac-49eb54479f6d
BARACLUDE
A entecavir product containing entecavir, registered in United States by E.R. Squibb & Sons, L.L.C.. The same ATC class is registered in 17 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Entecavir is registered in 17 of 19 countries.
Countries holding a registration under ATC J05AF10 (entecavir), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 10 of them publish a price we can compare per daily dose
Entecavir · ATC J05AF10
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of entecavir costs, country by country.
Normalised to the WHO defined daily dose (0.5 mg), the median price runs from $0.20 in United States to $12.37 in Switzerland — a ×61 gap.
- United States: $0.20 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Entecavir · price per daily dose (0.5 mg)
USD · FX 28 Sept 2026
- CH Switzerland$12.37
- FR France$7.50
- IT Italy$4.93
- US United States$0.20 (acquisition cost)
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ENTECAVIR
- Manufacturer
- E.R. Squibb & Sons, L.L.C.
- Country
- United States (US)
- ATC code
- J05AF10
- ATC class
- Entecavir
- Defined daily dose
- 0.5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1100031614121 BOTTLE in 1 CARTON (0003-1614-12) / 210 mL in 1 BOTTLE
- ndc110003-1614-12
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
56 interactions on record for entecavir.
Graded by severity as the source publishes them — 56 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Entecavir · interactions on record
56 records
- 56 moderate
Most severe, free to view
- CimetidineA02BA01moderate
- RanitidineA02BA02moderate
- FamotidineA02BA03moderate
- NeomycinA07AA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Entecavir in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBaraclude 0.05 mg/mlBristol-Myers Squibb Pharma
- SwitzerlandBaraclude 0.05 mg/mL, Lösung zum EinnehmenBristol-Myers Squibb SA
- CzechiaBARACLUDEBristol-Myers Squibb Pharma EEIG, Dublin
- SpainBARACLUDE 0,05 MG/ML SOLUCION ORALBristol-Myers Squibb Pharma Eeig
- FinlandBaracludeBristol-Myers Squibb Pharma EEIG
- FranceBARACLUDE 0,05 mg/ml, solution buvableBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- IrelandBaraclude 0.05 mg/ml oral solutionBristol-Myers Squibb Pharma EEIG
- IcelandBaracludeBristol-Myers Squibb Pharma EEIG*
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Entecavir Ratiopharm
- Bulgaria · Ентекавир Pharmascience International Ltd, Ентекавир Зентива
- Cyprus · Entevirem
- Czechia · Entecavir Fmk, Entecavir Sandoz
- Germany · Entecavir Al, Entecavir Amarox
- Denmark · Edevira, Entecavir Medical Valley
- Spain · Entecavir Aurovitas, Entecavir Dr. Reddys
- Finland · Entecavir Stada
- France · Entecavir Arrow, Entecavir Biogaran
- United Kingdom (Northern Ireland) · Entecavir Accord-Uk, Entecavir Amarox
- Greece · Edevira, Entecavir Sandoz
- Hungary · Entecavir Pharmascience International Ltd, Entecavir Teva
- Iceland · Baraclude, Entecavir Accord
- Italy · Entecavir Aristo, Entecavir Aurobindo
- Liechtenstein · Baraclude, Entecavir Accord
- Lithuania · Entecavir Sandoz
- Malta · Entecavir Dr. Reddy's, Entecavir Normon
- Netherlands · Entecavir Amarox, Entecavir Aurobindo
- Norway · Baraclude, Entecavir Accord
- Poland · Entecavir Aurovitas, Entecavir Polpharma
- Portugal · Entecavir Farmoz, Entecavir Generis
- Romania · Entecavir Labormed, Entecavir Sandoz
- Sweden · Entecavir Amarox, Entecavir Medical Valley
- Slovenia · Entekavir Sandoz, Entekavir Stada
- Slovakia · Entecavir Fmk
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5b895628-208f-471a-836c-d9abd72db5c0 GET /v1/drugs/5b895628-208f-471a-836c-d9abd72db5c0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": ".05",
"substance": "ENTECAVIR",
"productndc": "0003-1614",
"dosage_form": "SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "NDA021798",
"marketing_category": "NDA"
}See everything about entecavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.